Statistics for Bio-Rad Laboratories (id:8802 BIO)

Valuation metrics

Market cap

9.04B

Enterprise value

8.73B

Trailing P/E (ttm)

-14.83

Forward P/E

27.49

PEG ratio

27.49

Price/Sales (ttm)

3.50

Price/Book (mrq)

1.20

Enterprise Value/Revenue

3.38

Enterprise Value/EBITDA

18.06

Overview

Shares outstanding

22.92M

Float

19.44M

Shares short

651.70K

% Held by insiders

0.16%

% Held by institutions

0.78%

Average volume (10 days)

186.42K

Average volume (90 days)

Price summary

52-Week low

262.12

52-Week high

387.99

52-Week change

3.86%

Beta

0.94

50-Day moving average

340.44

200-Day moving average

317.29

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

March 08th, 2002

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-30.18%

Operating margin

9.94%

Operational effectiveness

Return on assets

1.86%

Return on equity

-9.79%

Income statement

Revenue (ttm)

90.82

Revenue per share (ttm)

90.82

Quarterly revenue growth (yoy)

5.15

Gross profit (ttm)

1.43B

EBITDA

541.40M

Net income to common (ttm)

-778,689,984.00

Diluted EPS (ttm)

-28.09

Quarterly earnings growth (yoy)

514.70%

Balance sheet

Total cash (mrq)

1.62B

Total cash per share (mrq)

57.95

Total debt (mrq)

1.39B

Total Debt/Equity (mrq)

18.54

Current ratio (mrq)

613.60%

Book value per share (mrq)

267.46

Cash flow

Cash flow statement

412.00M

Levered free cash flow (LFCF)

91.24M